The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Legend Biotech Corporation looks like a J&J acquisition target as Carvykti sales surge and Phase 2 data impress. Click for ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

If biotech funding continues to increase this year, Danaher could benefit.

But in the last three years, the company has sought to leverage its footholds in China and the U.S. to become a multinational ...

The deal for Kelonia Therapeutics is valued at $3.25 billion upfront.

The increase in nationwide vacancy to 23.2% is a reversal from the slight dip to end 2025, according to preliminary CBRE data ...

A high-security federal lab tucked into South San Francisco’s life-sciences hub is suddenly up for grabs, with a price tag ...

In biotech, the right connection can lead to roles that never reach public listings. From targeted event participation to authentic online engagement, networking is about creating trust that leads to ...